Now you are just straight lying. "The World Bank predicted global gross domestic product will expand 3.2 percent this year, from 2.4 percent in 2013, according to its twice-yearly "Global Economic Prospects." In the bank's last forecast in June, it expected global growth to reach 3 percent in 2014.
Now the $64,000 question (because that is about what I have left in dry powder) is how will TC trade until earnings? It seems to be an easy stock to slip under the radar. Might we get an opportunity for more shares at $2.6x?
And you know moly is going back below $10 how? It was foretold by Goldman Sachs that gold was going to $1050 in 2014 and over half the year is gone while gold is $1335.
What if moly goes to $20? then what? It could just as easily go to $20 as $10...as a matter of fact it might be more likely to hit $20 with expanding world economies.
Most of us are thinking adjusted net earnings of $0.08 to $0.13
Well what do you know! Today the analysts are raising their targets to right in the range we were predicting.
I was hoping molybdenum would stay above $15/lb.
That would have been a driver to get TC to $4 by this fall. I don't remember ever saying $5.75 and I feel the Jan 2015 $5 calls are too risky. A caveat (that mean exception) is the potential for a buyout, which is always there as long as TC is earning $0.10 per quarter and trading less than $3.
My trick is to put in a limit order below the lowest price TC achieves in the first hour of trading. Then I go fishing, gold panning or hiking.
These lawsuits rarely recover anything significant. It has to be proven that Endocyte knew the trial would be halted before the offering. Any shareholder who bought at $21 is probably still holding some stock in hopes of the pipeline so they are shooting themselves if they sign up to give away 30% of their money to a lawyer.
What fantasy land would MM deliver 247,000 oz of gold in 2014?
Sentiment: Strong Buy
Well actually that just fits right in with 80% of design capacity, which they achieved for a month already in June.
If we are at YTD 76,200 ounces gold and Royal knows something we don't, then the back half of 2014 TC is going to produce 93,800 ounces of gold.
Tis better to be running 80% in June than to be running higher in April and May and lower in June. Means we may seem some months this year at 85%.
Back in Kevin's day, Endako problems were blamed on ore oxidation and inexperience operating a brand new $500m mill. I don't know what they blame problems on today, but I think I would like to see TC sell it's 75% share there to it's partner.
Wow. That is probably the biggest decrease in short interest I have seen in a stock that wasn't a biotech.
lag. they run a bit less than 30 days behind for part of the sales. $12 is too low, $12.70 to $13 more realistic, especially now that we know a lot of the material came from TC and not Endako
Ok, yes I think you are right. For GAAP loss they use 171.6m and for profit they use 216m or thereabouts.
So it will be something like $43.5m/220m = $0.19 per diluted share using the above figures (which don't take into account depreciation, taxes, some other costs). I think the guys saying $0.10 to $0.13 are right in the ballpark.
Langeloth will deliver at least $4m to the revenue, which would put your estimate at $207m.
Yes well but it should have been 43.5/171.6 = 0.25 per diluted share (171.6m shares)
They won't be using the post Tmed share count this quarter.
Totally adjusted net income including depreciation and Perron's morning latte could be anywhere from $0.08 to $0.013